MOG and relapsing-remitting multiple sclerosis: The ability of methylation-specific primers to successfully detect DeMeth MOG-DNA from OPCs suggests that this approach may be used to detect ODC-derived MOG cfDNA in patients with relapsing-remitting MS (RRMS).